Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 131.55M CNY in the quarter ending September 30, 2026, with 12.65% growth. This brings the company's total for the last twelve months to 555.83M, up 8.92% year-over-year. In the year 2025, Zhejiang Haisen Pharmaceutical had annual revenue of 532.26M with 12.88% growth. That makes Zhejiang Haisen Pharmaceutical the 24,057th largest company in the world by revenue and 4,322nd in China.

• Revenue (ttm): 555.83M
• Revenue Growth: +8.92%
• P/S Ratio: 5.23
• Revenue / Employee: 788.41K
• Employees: 705
• Market Cap: 2.90B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 290.23M 54.5%
• China 242.03M 45.5%

Fiscal year ended Dec 31, 2025 See the full SHE:001367 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	532.26M	60.75M	12.88%
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error